Precision Medicine

The Precision Medicine Research Group at CHIP is committed to advancing individualized approaches to the prevention, diagnosis, and treatment of infectious and immune-related diseases. By integrating clinical data with genetic, molecular, and lifestyle information, we aim to uncover the biological mechanisms that drive variability in disease progression and treatment response.

Our work involves close collaboration with biobanks, laboratories, and international research networks to identify biomarkers, stratify patient populations, and support the development of targeted therapies. We apply advanced analytical methods, including machine learning and multi-omics integration, to translate complex data into actionable insights.

Through precision medicine, we strive to improve patient outcomes, reduce healthcare disparities, and support the evolution of more tailored and effective healthcare strategies.